@article{article, title  = {{Randomized trial of marker-directed versus standard schedule zoledronic acid for bone metastases from breast cancer.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{}},

 year = {{2012}},

 month = {{5}},

 author = {{Coleman RE and Wright J and Houston S and Agrawal R and Purohit OP-K and Hayward L and Simmonds P and Waterhouse A and Marshall H}},

 doi = {{10.1200/jco.2012.30.15_suppl.511}},

 volume = {{30}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{15_suppl}},

 pages = {{511-511}},

 note = {{Accessed on 2025/10/10}}}